Roche cites drug interactions in mibefradil withdrawal.
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D000075202:Contraindications; D004347:Drug Interactions; D004335:Drug and Narcotic Control; D006801:Humans; D020748:Mibefradil; D013764:Tetrahydronaphthalenes; D014481:United States; D014665:Vasodilator Agents
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D014665:Vasodilator Agents; D020748:Mibefradil